**REGISTERED CHARITY NUMBER: 1026791** 

## **REPORT OF THE TRUSTEES AND** 

**UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025** 

**FOR GUTS (GUILDFORD UNDETECTED TUMOUR SCREENING)** 

Centora James Limited Jury Farm Ripley Lane West Horsley KT24 6JT 



**GUTS (GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025** 

||**Page**|
|---|---|
|**Report of the Trustees**|1 to 3|
|**Independent Examiner's Report**|4|
|**Statement of Financial Activities**|5|
|**Balance Sheet**|6|
|**Notes to the Financial Statements**|7 to 11|
|**Detailed Statement of Financial Activities**|12 to 13|





**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **REPORT OF THE TRUSTEES** 

## **FOR THE YEAR ENDED 31 MARCH 2025** 

## **INTRODUCTION** 

In the United Kingdom, around 18,000 people die from colon cancer every year. Many of those deaths could be prevented by earlier diagnosis. People over 50 and anyone with a history of colon cancer in the family, who experience changes in their bowel habit, are particularly at risk. GUTS was set up in 1983 with the stated purpose of improving the early detection of bowel cancer. The charity established one of the first local population screening programmes for bowel cancer, working with GP practices in Surrey, West Sussex and Hampshire. In 2006 a Bowel Cancer Screening Programme was set up in England and, with the active and financial support of GUTS, the centre for the South of England was based in Guildford. This programme currently offers screening to everyone between the ages 50 and 74, and is available, on request, beyond 74 years of age. For those outside this age range, GUTS continues to advise families and others at risk, through its Colorectal Cancer Family Clinic. 

## **ORGANISATION STRUCTURE, GOVERNANCE AND MANAGEMENT OF THE CHARITY** 

The Trust is an unincorporated body set up by Trust Deed dated 7th September 1993 as amended on 5 December 2007, and is a registered charity. The current Trustees are set out on Page 1. Trustees are required to administer the charitable trust in accordance with the Trust Deed and conform to the requirements of the Charity Commission and Inland Revenue. The day-to-day management of the Trust lies with the Executive Committee and Fundraising Committee, details of which are set out below. The Trust Deed requires there to be at least three Trustees. All trustees shall, by virtue of his or her personal or professional qualifications, be able to make a contribution to the pursuit of the objects or the management of the charity. 

The present trustees have the following specific responsibilities in addition to their collective role: 

Mr Iain Jourdan FRCS - Chairman and director of all medical matters Mr J F Stebbing - Medical matters Mr M Sharpe - Finance and regulatory matters (resigned March 2025) 

The induction process for any new Trustee comprises an initial meeting with the Chairman, followed by meetings with not less than two other Trustees. A new Trustee would be appointed by a resolution of the Trustees passed at a special meeting, after the new Trustee has signed a declaration of their acceptance and willingness to act in the interests of the charity. 

The trustees have examined the major strategic, business and operational risks to which the charity is exposed, and confirm that systems and procedures are in place to manage those risks. 

## **GUTS Committee Structure** 

The Executive Committee, currently chaired by Mr Iain Jourdan, shall comprise the Trustees, Treasurer and Fundraising Coordinator and be responsible for policy, funding and charitable expenditure, staffing, legal and financial matters 

## **Executive Committee Members (at 31 March 2025)** 

Iain Jourdan (Chairman from 1 June 2010) Prof T A Rockall (Trustee) Phill Davis (Trustee) Andrea Scala (Trustee) Dena Dixon (Trustee) John Stebbing (Trustee) Prof S P Halloran (Trustee until December 2024) Matt Sharpe (Treasurer & Trustee until March 2025) Dr Anisha Patel (Trustee from June 2024 ) Edward Wells (Trustee) James Read (Trustee) Jayne White (Trustee) Nerissa Deeks (Fundraising Manager) 

## **OPERATIONAL PERSONNEL** 

## **Management of the Family Cancer Clinic** 

Nicola Hounsham administers the GUTS Family Cancer Clinic, providing counselling and screening to families with a history of cancer. This clinic is wholly funded by GUTS. 

## **Fundraising** 

Nerissa Deeks is responsible for coordinating fundraising and day-to-day running of the charity, with part-time help from Imogen Smith. 

## **Treasurer** 

Matt Sharpe was the Treasurer, responsible for book-keeping and recording all financial transactions, and for legal and administrative matters. Mr Sharpe resigned as a Trustee in March 2025. 

Page 1 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **REPORT OF THE TRUSTEES** 

## **FOR THE YEAR ENDED 31 MARCH 2025** 

## **OBJECTIVES AND ACTIVITIES FOR THE PUBLIC BENEFIT** 

The formal objectives of GUTS are: 

"the preservation and protection of good health by screening and undertaking or assisting in the undertaking of research for the early detection and treatment of cancer and other diseases of the digestive system and the publication of the useful results of such research." 

GUTS works towards these objectives by funding: 

- The Colorectal Family Cancer Clinic which offers counselling and screening regimes for people at moderate/high risk of developing bowel cancer by virtue of a strong family history. 

- Clinical and research projects where the researchers' areas of interest further the objects of the charity. 

- Donating appropriate medical equipment as and when the need arises and when alternative sources of funding are not readily available. 

The Trustees confirm that they have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the Trust's aims and objectives and when planning future activities and setting the grant making policies for the year. 

## **ACHIEVEMENTS, PERFORMANCE AND FUTURE DEVELOPMENTS** 

## **Colorectal Cancer Family Clinic** 

The GUTS Colorectal Cancer Family Clinic continues to provide appropriate advice to individuals with a family history of bowel cancer, applying national referral guidelines overseen by surgeons and gastroenterologists at the Royal Surrey County Hospital. Individuals at low or low/moderate risk receive written advice including recommendations for future screening. Individuals at high/moderate or high risk are offered a clinic appointment for risk assessment, counselling and screening. Genetic testing is made available to identify inherited conditions within families that may have a high risk of developing colorectal cancers. 

## **Supporting Research** 

**Papillon Colorectal Database:** GUTS is working with the charity 'Bright' on this project. Thanks to funding from GUTS, amounting to an annual grant of £31,000, a computer scientist is now working to redesign the database to improve its functionality and progress it to the next stage which is to build a central bank of information based on patient experience (PROMS). The project is known as the CITRuS Study. Although the study was originally designed for people treated with Papillon radiotherapy it has now been extended to include other bowel cancer patients. 

During this period the second stage of the project was completed. This involved the recruitment of patients willing to complete questionnaires before, during, and at the end of their treatment. These questionnaires are designed to gauge the range of symptoms and side-effects that patients experience at different stages of their treatment and recovery. 

The data collected from the questionnaires will be used to inform and prepare new patients as they begin treatment. Eventually, patients will be able to log into a portal in order to access information and advice regarding their treatment and self-management of symptoms and side-affects. 

In March 2025 the Trustees agreed to continue funding this project for another two years. 

## **Support for patients at the end of treatment** 

During this period plans to introduce this new service were being developed. As a result of their treatment for bowel cancer, patients often experience legacy symptoms that can be difficult to manage and have other psychological/social issues to deal with too. There is currently very little support for this area, and trustees agreed that more should be done. The starting point was a new GUTS website that provides more detailed information and signposting, presented in a user-friendly way. The website went 'live' during this period. 

Further plans for delivering face-to-face support for such patients are in development; a sub-committee of Trustees, staff and clinical personnel was established to plan the structure and implementation of the service. The committee sought advice from Bowel Cancer UK and Clinical Nurse Specialist Claire Coughlan who had recently established a similar service at Lewisham Hospital. She provided documentation and advice and the GUTS project ('The Bowel Owl') is going to be based on this model. The committee has also been working with the Fountain Centre, which will be providing some of the counselling and psychological expertise for the service users. 

Page 2 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **REPORT OF THE TRUSTEES** 

## **FOR THE YEAR ENDED 31 MARCH 2025** 

## **Fundraising** 

The fundraising team introduced a new initiative of gift boxes for patients undergoing treatment. The contents of the boxes include information in the form of GUTS leaflets and a copy of Dr Anisha Patel's book 'Everything you hoped you would never need to know about bowel cancer', moisturisers to alleviate skin irritation caused by treatment and other useful items. The boxes are available free of charge for patients and they can be sponsored by families, ex patients, corporate supporters etc. At this point there were are more sponsors than patients taking boxes. 

This year was a good one for fundraising events. Regular fundraising events, included the Hoopwick Clay Pigeon Shoot, which raised over £25,000, the Jazz in the Park event on Loseley Estate (£6,500) and the GUTS Motor Tour (£8,000). In addition, a fundraising lunch attended by Stephen Mangan raised £4,000. Supporter-led events also raised significant amounts, including a team taking part in the Weymouth Beach Race in memory of a former patient, raising £3,000. 

It was an exceptionally good year for legacy income, which totalled £175,000. 

## **INVESTMENT POLICY AND PERFORMANCE ACHIEVED AGAINST THE POLICY** 

With a large proportion of our assets in cash deposits and fixed interest stocks, the balance of our investments was linked to the UK Equity market. The performance has broadly matched the movement in that market. 

## **RESERVES POLICY** 

The Trust's charitable activities include the development and maintenance of a cancer screening and counselling service, and the financing of cancer research over a number of contiguous areas which, to be effective, requires a commitment to funding over the medium term. Having regard to this, Trustees have established a policy whereby unrestricted funds, not committed or invested in tangible fixed assets (the free reserves), should be maintained at a level sufficient to finance around two years' charitable expenditure. 

## **ETHICAL POLICY** 

The ethical policy adopted and published by GUTS is based on principles recommended by the National Council for Voluntary Organisations (NCVO), of which GUTS is a member. GUTS conducts its affairs as far as possible in accordance with those principles. 

## **ACKNOWLEDGEMENTS** 

The Trustees wish to place on record that they are grateful to the many GUTS supporters who do so much to make our work possible. We also thank all GUTS staff and volunteers for their hard work and dedication. 

## **REFERENCE AND ADMINISTRATIVE DETAILS** 

|**Registered Charity number:**|1026791|
|---|---|
|**Principal address:**|GUTS Office, Level A|
||Royal Surrey NHS Foundation Trust|
||Egerton Road|
||Guildford|
||Surrey|
||GU2 7XX|
|**Independent Examiner:**|K D N De Silva|
||Centora James Limited|
||Jury Farm|
||Ripley Lane|
||West Horsley|
||KT24 6JT|



Approved by order of the board of trustees on 30 January 2026 and signed on its behalf by: 

Mrs D Dixon Trustee 

Page 3 



**INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF GUTS (GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **Independent examiner's report to the trustees of GUTS (Guildford Undetected Tumour Screening)** 

I report to the charity trustees on my examination of the accounts of GUTS (Guildford Undetected Tumour Screening) (the Trust) for the year ended 31 March 2025. 

## **Responsibilities and basis of report** 

As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act'). 

I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act. 

## **Independent examiner's statement** 

Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Association of Chartered Certified Accountants, which is one of the listed bodies. 

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or 

2. the accounts do not accord with those records; or 

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. 

K D N De Silva 

The Association of Chartered Certified Accountants 

Centora James Limited Jury Farm Ripley Lane West Horsley KT24 6JT 

Date: 30 January 2026 

Page 4 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2025** 

|||31.3.25|31.3.24|
|---|---|---|---|
|||Unrestricted|Total|
|||fund|funds|
||Notes|£|£|
|**INCOME AND ENDOWMENTS FROM**||||
|Donations and legacies||209,006|259,250|
|Other trading activities|2|58,742|63,041|
|Investment income|3|49,439|48,317|
|**Total**||317,187|370,608|
|**EXPENDITURE ON**||||
|Raising funds|4|74,204|92,525|
|**Charitable activities**||||
|General||84,622|33,795|
|Support costs||23,535|6,456|
|Other||461|605|
|**Total**||182,822|133,381|
|Net gains/(losses) on investments||(34,196)|1,900|
|**NET INCOME**||100,169|239,127|
|**RECONCILIATION OF FUNDS**||||
|Total funds brought forward||760,010|520,883|
|**TOTAL FUNDS CARRIED FORWARD**||860,179|760,010|



The notes form part of these financial statements 

Page 5 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **BALANCE SHEET 31 MARCH 2025** 

|Notes<br>**FIXED ASSETS**<br>Tangible assets<br>7<br>Investments<br>8<br>**CURRENT ASSETS**<br>Debtors<br>9<br>Cash at bank and in hand<br>**CREDITORS**<br>Amounts falling due within one year<br>10<br>**NET CURRENT ASSETS**<br>**TOTAL ASSETS LESS CURRENT LIABILITIES**<br>**NET ASSETS**<br>**FUNDS**<br>11<br>Unrestricted funds<br>**TOTAL FUNDS**|31.3.25<br>Unrestricted<br>fund<br>£<br>530<br>485,064<br>485,594<br>10,066<br>373,775<br>383,841<br>(9,256)<br>374,585<br>860,179<br>860,179<br>860,179<br>860,179|31.3.24<br>Total<br>funds<br>£<br>272<br>487,863|
|---|---|---|
|||488,135<br>9,425<br>268,756|
|||278,181<br>(6,306)|
|||271,875|
|||760,010|
|||760,010|
|||760,010|
|||760,010|



The financial statements were approved by the Board of Trustees and authorised for issue on 30 January 2026 and were signed on its behalf by: 

Mrs D Dixon Trustee 

The notes form part of these financial statements 

Page 6 



**GUTS (GUILDFORD UNDETECTED TUMOUR SCREENING)** 

**NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025** 

## **1. ACCOUNTING POLICIES** 

## **Basis of preparing the financial statements** 

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value. 

## **Income** 

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. 

## **Expenditure** 

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. 

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure. 

## **Tangible fixed assets** 

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. 

|Plant and machinery|-|25% on reducing balance|
|---|---|---|
|Fixtures and fittings|-|33% on cost|
|Motor vehicles|-|25% on reducing balance|
|Computer Equipment|-|20% on cost|



## **Taxation** 

The charity is exempt from tax on its charitable activities. 

## **Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. 

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. 

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements. 

## **Pension costs and other post-retirement benefits** 

The charity operates a defined contribution pension scheme. Contributions payable to the charity's pension scheme are charged to the Statement of Financial Activities in the period to which they relate. 

continued... 

Page 7 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025** 

## **2. OTHER TRADING ACTIVITIES** 

|**2.**|**OTHER TRADING ACTIVITIES**|||
|---|---|---|---|
|||31.3.25|31.3.24|
|||£|£|
||Fundraising events|58,742|63,041|
|**3.**|**INVESTMENT INCOME**|||
|||31.3.25|31.3.24|
|||£|£|
||Other fixed asset invest - FII|48,251|48,127|
||Deposit account interest|1,188|190|
|||49,439|48,317|
|**4.**|**RAISING FUNDS**|||
||**Raising donations and legacies**|||
|||31.3.25|31.3.24|
|||£|£|
||Staff costs|37,605|39,888|
||Cost of events|18,193|20,457|
||Advertising|8,492|2,255|
||Website costs|2,520|22,880|
|||66,810|85,480|
||**Investment management costs**|||
|||31.3.25|31.3.24|
|||£|£|
||Portfolio management|7,394|7,045|
||Aggregate amounts|74,204|92,525|



## **5. TRUSTEES' REMUNERATION AND BENEFITS** 

There were no trustees' remuneration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024. 

## **Trustees' expenses** 

There were no trustees' expenses paid for the year ended 31 March 2025 nor for the year ended 31 March 2024. 

continued... 

Page 8 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025** 

## **6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** 

|**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES**||
|---|---|
||Unrestricted|
||fund|
||£|
|**INCOME AND ENDOWMENTS FROM**||
|Donations and legacies|259,250|
|Other trading activities|63,041|
|Investment income|48,317|
|**Total**|370,608|
|**EXPENDITURE ON**||
|Raising funds|92,525|
|**Charitable activities**||
|General|33,795|
|Support costs|6,456|
|Other|605|
|**Total**|133,381|
|Net gains on investments|1,900|
|**NET INCOME**|239,127|
|**RECONCILIATION OF FUNDS**||
|Total funds brought forward|520,883|
|**TOTAL FUNDS CARRIED FORWARD**|760,010|



|**7.**<br>**TANGIBLE FIXED ASSETS**<br>Fixtures<br>Plant and<br>and<br>Motor<br>Computer<br>machinery<br>fittings<br>vehicles<br>equipment<br>£<br>£<br>£<br>£<br>**COST**<br>At 1 April 2024<br>307<br>644<br>13,250<br>-<br>Additions<br>-<br>-<br>-<br>399<br>At 31 March 2025<br>307<br>644<br>13,250<br>399<br>**DEPRECIATION**<br>At 1 April 2024<br>271<br>644<br>13,014<br>-<br>Charge for year<br>9<br>-<br>59<br>73<br>At 31 March 2025<br>280<br>644<br>13,073<br>73<br>**NET BOOK VALUE**<br>At 31 March 2025<br>27<br>-<br>177<br>326<br>At 31 March 2024<br>36<br>-<br>236<br>-|Totals<br>£<br>14,201<br>399|
|---|---|
||14,600|
||13,929<br>141|
||14,070|
||530|
||272|



continued... 

Page 9 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025** 

|**8.**<br>**FIXED ASSET INVESTMENTS**<br>**MARKET VALUE**<br>At 1 April 2024<br>Revaluation<br>At 31 March 2025<br>**NET BOOK VALUE**<br>At 31 March 2025<br>At 31 March 2024<br>**9.**<br>**DEBTORS**<br>Amounts falling due within one year:<br>Other debtors<br>Prepayments<br>Amounts falling due after more than one year:<br>Trade debtors<br>Aggregate amounts<br>**10.**<br>**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**<br>Taxation and social security<br>Other creditors<br>**11.**<br>**MOVEMENT IN FUNDS**<br>**Unrestricted funds**<br>General fund<br>**TOTAL FUNDS**|Listed<br>investments<br>£<br>487,863<br>(2,799)<br>485,064<br>485,064<br>487,863<br>31.3.25<br>31.3.24<br>£<br>£<br>7<br>190<br>1,067<br>1,011<br>1,074<br>1,201<br>8,992<br>8,224<br>10,066<br>9,425<br>31.3.25<br>31.3.24<br>£<br>£<br>4,773<br>2,708<br>4,483<br>3,598<br>9,256<br>6,306<br>Net<br>movement<br>At<br>At 1.4.24<br>in funds<br>31.3.25<br>£<br>£<br>£<br>760,010<br>100,169<br>860,179<br>760,010<br>100,169<br>860,179|Listed<br>investments<br>£<br>487,863<br>(2,799)<br>485,064<br>485,064<br>487,863<br>31.3.25<br>31.3.24<br>£<br>£<br>7<br>190<br>1,067<br>1,011<br>1,074<br>1,201<br>8,992<br>8,224<br>10,066<br>9,425<br>31.3.25<br>31.3.24<br>£<br>£<br>4,773<br>2,708<br>4,483<br>3,598<br>9,256<br>6,306<br>Net<br>movement<br>At<br>At 1.4.24<br>in funds<br>31.3.25<br>£<br>£<br>£<br>760,010<br>100,169<br>860,179<br>760,010<br>100,169<br>860,179|
|---|---|---|
|||485,064|
|||485,064|
|||487,863|
|||31.3.24<br>£<br>190<br>1,011<br>1,201<br>8,224<br>9,425<br>31.3.24<br>£<br>2,708<br>3,598<br>6,306<br>At<br>31.3.25<br>£<br>860,179|
|||860,179|



There were no investment assets outside the UK. 

continued... 

Page 10 



**GUTS** 

## **(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 MARCH 2025** 

## **11. MOVEMENT IN FUNDS - continued** 

Net movement in funds, included in the above are as follows: 

|**Unrestricted funds**<br>General fund<br>**TOTAL FUNDS**|Incoming<br>Resources<br>resources<br>expended<br>£<br>£<br>317,187<br>(182,822)<br>317,187<br>(182,822)|Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>(34,196)<br>100,169<br>(34,196)<br>100,169|Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>(34,196)<br>100,169<br>(34,196)<br>100,169|
|---|---|---|---|
||||100,169|



## **Comparatives for movement in funds** 

|**Unrestricted funds**<br>General fund<br>**TOTAL FUNDS**|Net<br>movement<br>At 1.4.23<br>in funds<br>£<br>£<br>520,883<br>239,127<br>520,883<br>239,127|At<br>31.3.24<br>£<br>760,010|
|---|---|---|
|||760,010|



Comparative net movement in funds, included in the above are as follows: 

|**Unrestricted funds**<br>General fund<br>**TOTAL FUNDS**|Incoming<br>Resources<br>resources<br>expended<br>£<br>£<br>370,608<br>(133,381)<br>370,608<br>(133,381)|Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>1,900<br>239,127<br>1,900<br>239,127|Gains and<br>Movement<br>losses<br>in funds<br>£<br>£<br>1,900<br>239,127<br>1,900<br>239,127|
|---|---|---|---|
||||239,127|



## **12. RELATED PARTY DISCLOSURES** 

There were no related party transactions for the year ended 31 March 2025. 

Page 11 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2025** 

|**DETAILED STATEMENT OF FINANCIAL ACTIVITIES**<br>**FOR THE YEAR ENDED 31 MARCH 2025**|||
|---|---|---|
||31.3.25|31.3.24|
||£|£|
|**INCOME AND ENDOWMENTS**|||
|**Donations and legacies**|||
|Donations|33,096|43,218|
|Legacies|175,910|216,032|
||209,006|259,250|
|**Other trading activities**|||
|Fundraising events|58,742|63,041|
|**Investment income**|||
|Other fixed asset invest - FII|48,251|48,127|
|Deposit account interest|1,188|190|
||49,439|48,317|
|**Total incoming resources**|317,187|370,608|
|**EXPENDITURE**|||
|**Raising donations and legacies**|||
|Wages|36,696|39,007|
|Pensions|909|881|
|Cost of events|18,193|20,457|
|Advertising|8,492|2,255|
|Website costs|2,520|22,880|
||66,810|85,480|
|**Investment management costs**|||
|Portfolio management|7,394|7,045|
|**Charitable activities**|||
|Medical staff salaries|5,568|5,568|
|Grants to institutions|80,763|28,220|
|Grants to individuals|721|657|
||87,052|34,445|
|**Other**|||
|Bank Fees|461|605|



This page does not form part of the statutory financial statements 

Page 12 



**GUTS** 

**(GUILDFORD UNDETECTED TUMOUR SCREENING)** 

## **DETAILED STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 MARCH 2025** 

|**DETAILED STATEMENT OF FINANCIAL ACTIVITIES**<br>**FOR THE YEAR ENDED 31 MARCH 2025**|||
|---|---|---|
||31.3.25|31.3.24|
||£|£|
|**Support costs**|||
|**Governance costs**|||
|Insurance|2,324|722|
|Postage and stationery|1,715|200|
|Sundries|655|855|
|Accountancy and legal fees|2,940|2,940|
|Legal Expenses|10,975|-|
|Motor Vehicle Expenses|1,645|872|
|IT software and consumables|710|47|
|Telephone|-|79|
|Plant and machinery|9|12|
|Motor vehicles|59|79|
|Computer equipment|73|-|
||21,105|5,806|
|Total resources expended|182,822|133,381|
|**Net income before gains and losses**|134,365|237,227|
|**Realised recognised gains and losses**|||
|Realised gains/(losses) on investment property|(34,196)|1,900|
|**Net income**|100,169|239,127|



This page does not form part of the statutory financial statements 

Page 13